IT8249241A0 - Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione, utile per il trattamento dell'infarto miocardico - Google Patents

Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione, utile per il trattamento dell'infarto miocardico

Info

Publication number
IT8249241A0
IT8249241A0 IT8249241A IT4924182A IT8249241A0 IT 8249241 A0 IT8249241 A0 IT 8249241A0 IT 8249241 A IT8249241 A IT 8249241A IT 4924182 A IT4924182 A IT 4924182A IT 8249241 A0 IT8249241 A0 IT 8249241A0
Authority
IT
Italy
Prior art keywords
useful
treatment
pharmaceutical composition
composition containing
myocardial infarction
Prior art date
Application number
IT8249241A
Other languages
English (en)
Other versions
IT1189379B (it
Inventor
Borrelli Francesco
Antonetti Francesco
Original Assignee
Serono Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ist Farm filed Critical Serono Ist Farm
Publication of IT8249241A0 publication Critical patent/IT8249241A0/it
Priority to IT49241/82A priority Critical patent/IT1189379B/it
Priority to AU19883/83A priority patent/AU559192B2/en
Priority to DE198383830192T priority patent/DE106812T1/de
Priority to DE8383830192T priority patent/DE3380166D1/de
Priority to AT83830192T priority patent/ATE44467T1/de
Priority to EP83830192A priority patent/EP0106812B1/en
Priority to ES526300A priority patent/ES8704736A1/es
Priority to ZA837484A priority patent/ZA837484B/xx
Priority to DK464483A priority patent/DK161564C/da
Priority to CA000438588A priority patent/CA1217717A/en
Priority to JP58187167A priority patent/JPS5989630A/ja
Priority to IL69938A priority patent/IL69938A/xx
Priority to US06/669,462 priority patent/US4568543A/en
Application granted granted Critical
Publication of IT1189379B publication Critical patent/IT1189379B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
IT49241/82A 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico IT1189379B (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico
AU19883/83A AU559192B2 (en) 1982-10-08 1983-10-05 Composition for treating myocardial infarction
DE198383830192T DE106812T1 (de) 1982-10-08 1983-10-05 Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
DE8383830192T DE3380166D1 (en) 1982-10-08 1983-10-05 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
AT83830192T ATE44467T1 (de) 1982-10-08 1983-10-05 Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
EP83830192A EP0106812B1 (en) 1982-10-08 1983-10-05 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
ES526300A ES8704736A1 (es) 1982-10-08 1983-10-06 Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio.
ZA837484A ZA837484B (en) 1982-10-08 1983-10-06 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor,useful for the treatment of myocardium infarction
DK464483A DK161564C (da) 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase
CA000438588A CA1217717A (en) 1982-10-08 1983-10-07 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
JP58187167A JPS5989630A (ja) 1982-10-08 1983-10-07 心筋梗塞治療剤
IL69938A IL69938A (en) 1982-10-08 1983-10-09 Pharmaceutical compositions containing hyaluronidase together with urokinase
US06/669,462 US4568543A (en) 1982-10-08 1984-11-08 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico

Publications (2)

Publication Number Publication Date
IT8249241A0 true IT8249241A0 (it) 1982-10-08
IT1189379B IT1189379B (it) 1988-02-04

Family

ID=11270058

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico

Country Status (12)

Country Link
US (1) US4568543A (it)
EP (1) EP0106812B1 (it)
JP (1) JPS5989630A (it)
AT (1) ATE44467T1 (it)
AU (1) AU559192B2 (it)
CA (1) CA1217717A (it)
DE (2) DE106812T1 (it)
DK (1) DK161564C (it)
ES (1) ES8704736A1 (it)
IL (1) IL69938A (it)
IT (1) IT1189379B (it)
ZA (1) ZA837484B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
AU5045690A (en) * 1989-01-27 1990-08-24 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
JPH10511356A (ja) * 1994-12-22 1998-11-04 スミスクライン・ビーチャム・コーポレイション フィブリノゲン受容体拮抗物質
US7807618B2 (en) * 2002-05-20 2010-10-05 The Board Of Regents Of The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179787A (en) * 1967-03-22 1970-01-28 Biorex Laboratories Ltd Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) * 1979-03-07 1981-06-02 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration

Also Published As

Publication number Publication date
ATE44467T1 (de) 1989-07-15
AU1988383A (en) 1984-04-12
EP0106812A3 (en) 1985-09-11
IL69938A0 (en) 1984-01-31
IL69938A (en) 1987-09-16
US4568543A (en) 1986-02-04
DK464483D0 (da) 1983-10-07
ZA837484B (en) 1984-06-27
DK464483A (da) 1984-04-09
DE3380166D1 (en) 1989-08-17
ES8704736A1 (es) 1987-05-01
DK161564C (da) 1992-01-06
DK161564B (da) 1991-07-22
IT1189379B (it) 1988-02-04
JPS5989630A (ja) 1984-05-23
ES526300A0 (es) 1987-05-01
EP0106812B1 (en) 1989-07-12
CA1217717A (en) 1987-02-10
JPS6150927B2 (it) 1986-11-06
DE106812T1 (de) 1984-08-30
EP0106812A2 (en) 1984-04-25
AU559192B2 (en) 1987-02-26

Similar Documents

Publication Publication Date Title
PH23357A (en) Cyclosporin compound,pharmaceutical composition containing said compound and method of use thereof
HUT41418A (en) Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents
DE3271990D1 (en) Therapeutically active compound and pharmaceutical composition containing the same
NL192201B (nl) Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en prepa- raten die deze verbindingen bevatten.
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
GB8729404D0 (en) Hydrosols of pharmacologically active agents & pharmaceutical compositions comprising them
FR2571966B1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
PH24719A (en) Cephem compound, pharmaceutical composition containing said compound and method of use thereof
PH22821A (en) Phenyl butenamide, pharmaceutical composition containing said compound and method of use thereof
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
IT8249241A0 (it) Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione, utile per il trattamento dell'infarto miocardico
IT8719048A0 (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
IT8348031A0 (it) Composizione farmaceutica contenente un composto di 1,4-benzochinone e suo impiego come agente antifibro tico
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
GB2165453B (en) Pharmaceutical agent for the local treatment of psoriasis
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
PH24057A (en) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-ene derivatives,pharmaceutical composition containing said compounds and method of use thereof
PH21606A (en) Penem compounds, pharmaceutical composition containing said compounds and method of use thereof
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
PH24690A (en) 8 alpha(-acylaminoergoline, pharmaceutical composition containing said compound and method of use thereof
IT8819447A0 (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961008